Randomized phase II study of docetaxel plus estramustine and single-agent docetaxel in patients with metastatic hormone-refractory prostate cancer
Eymard, J-C, Priou, F, Zannetti, A, Ravaud, A, Lepille, D, Kerbrat, P, Gomez, P, Paule, B, Genet, D, Herait, P, Ecstein-Fraisse, E, Joly, FVolume:
18
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdm083
Date:
April, 2007
File:
PDF, 109 KB
english, 2007